Calcium Hydroxyapatite
Global leading hydroxyapatite manufacturer
In China,for Global
Hundreds of thousands of units of dermal fillers have been formulated using our CaHA
In 2018, we established our hydroxyapatite facility and simultaneously began R&D on both porous and dense microspheres. Today, we are serving the entire globe.
Leveraging the expertise of our team, who have been deeply engaged in the R&D and manufacturing of hydroxyapatite microspheres(CaHA) for decades, our products are now exported to multiple markets worldwide. Our manufacturing quality system has also passed stringent audits by several leading enterprises, demonstrating a world-class supply chain assurance capability. These hydroxyapatite microspheres are widely used in the production of medical and vaccine products.
CaHA is a bioactive ceramic whose chemical composition closely resembles human bone mineral, offering excellent biocompatibility and predictable in vivo behavior. CaHA-based fillers are widely recognized for their dual effects of immediate volumization and long-term tissue regeneration. With a regular spherical morphology and excellent flowability, hydroxyapatite can be uniformly dispersed in gel carriers, enabling stable and controllable injection procedures.
We provide high-purity spherical hydroxyapatite (CaHA) microspheres, specifically designed for soft tissue augmentation and regenerative aesthetics. Our three distinct product variants address diverse clinical needs—from long-lasting structural support to bioactive stimulation. With precise particle size control, stable crystalline phase structure, and a reproducible manufacturing process, we deliver reliable core raw material solutions for injectable filler manufacturers.
Over the past few years, we have successively published a series of educational and R&D insights on CaHA and CaHA-based fillers. All of these articles are available on our article hub. Feel free to browse our articles for development inspiration (primarily in Chinese).
01
Perfectly Shaped
Precision sintering and granulation technology make the spheres liquid-like.
02
Crystallinity on Demand
High crystallinity offers long-term structural support and bio-stimulation, while low crystallinity degrades rapidly to release ions. Tailored to your specific needs.
03
Multiple Particle Sizes
Precision sieving and proprietary equipment minimize size deviation, precisely meeting your diverse clinical design requirements.
Innovation leader of hydroxyapatite microspheres
We are leading the innovation and manufacture of CaHA and CaHA-based fillers. Leveraging decades of technical expertise and advanced manufacturing processes, we provide customized CaHA solutions to global clients, meeting the diverse needs of various clinical application scenarios.
Exceptional Quality, Ensuring Superior Performance
Our CaHA product lines cover two distinct series: injectable-grade and chromatographic-grade. CaHA for injection covers specialized grades as shown to the left. Through precise modulation of crystallinity and microstructure, we achieve programmable degradation cycles ranging from 3–6 months to over 24 months. Utilizing an innovative sintering process, our microspheres feature a perfectly spherical morphology and excellent flowability.
Serving the Global Market
Global aesthetic markets demand CaHA materials with excellent biocompatibility, morphological consistency, and reproducible, scalable manufacturing. Any fluctuation in particle size, shape, or purity directly impacts product performance, safety, and regulatory outcomes. Our CaHA microspheres are now shipping to multiple countries and regions worldwide, providing robust, high-quality raw materials for millions of CaHA injectable units. We are dedicated to supplying global aesthetic clients with high-quality, highly consistent CaHA and comprehensive tech support.
Tailored to your needs
Precisely engineered by degradation time
Professional medical and aesthetic anti-aging series of products, for light medical beauty clinical scene research and development. Based on the mechanism of skin aging, focus postoperative repair and layered anti-aging, standardized quality control production, formula affinity and stability.
MPlc-Porous low crystallization: Featuring a highly porous surface structure and low crystallinity, MPlc offers a larger specific surface area and enhanced bioactivity. Upon implantation, they rapidly release calcium and phosphate ions, actively promoting host cell infiltration and collagen regeneration. Ideal for filling applications requiring rapid tissue integration and regenerative effects.
SMP-Porous high crystallization: Retaining their porous structure while featuring higher crystallinity, SMP possess a more stable framework. The combination of porosity and high crystallinity achieves a balance between bioactivity and structural durability—supporting tissue ingrowth while providing extended volume maintenance. Suitable for indications requiring both regenerative stimulation and long-lasting support.
GS-Solid high crystallization: A dense structure and exceptionally high crystallinity give these microspheres maximum compressive strength and the slowest degradation rate. Their regular spherical morphology and narrow size distribution ensure uniform dispersion in gels and smooth injectability. Ideal for deep-tissue filling and contouring that demand the highest levels of structural support and durability.
Compressive Strength
Compressive strength up to 10 MPa, effectively withstanding shear forces and turbulence during injection
Buffer compatibility
Compatible with a wide range of buffer systems, ensuring your product's safety thresholds are met
Sterility Control
Sterile and microbial-limit CaHA are both available, facilitating the development of products that require aseptic processing
Loss on drying
Despite the highly hygroscopic nature of hydroxyapatite, we strictly control the loss on drying (LOD) of our microspheres to<0.1%.
Sphericity and morphology
Aspect ratio close to 1 ensures near-perfect spherical morphology, with virtually no irregular particles.
Particle size
We offer a wide range of particle sizes to facilitate the development of products targeting different treatment depths.
α-TCP and β-TCPa
Tricalcium phosphate (TCP) is a vital bioactive ceramic material within the calcium phosphate family. While sharing the same calcium phosphate system as hydroxyapatite (HA), it exhibits distinctly different degradation behaviors and biological performances. TCP primarily exists in two crystalline phases: α and β. Both phases share the same chemical composition (Ca₃(PO₄)₂, with a Ca/P molar ratio of 1.5) but possess completely different crystal structures: α-TCP has a monoclinic crystal system, whereas β-TCP has a trigonal crystal system. Both phases exhibit excellent biocompatibility, osteoconductivity, and biodegradability, and have been widely applied in orthopedics, oral and maxillofacial surgery, and plastic surgery.
We are mow providing high-purity β-TCP microspheres/powders characterized by controllable particle size distribution, high phase purity, and excellent batch-to-batch consistency.
Amorphous particles (Amourpus)
Amorphous nanoparticles of CaHA and TCP are a class of non-crystalline or weakly crystalline calcium phosphate nanomaterials, whose structures closely resemble the precursor phases of natural bone mineral and tooth enamel. Lacking a long-range ordered crystal lattice, these particles typically exhibit a significantly higher specific surface area and a faster degradation/ion release rate, along with outstanding surface reactivity.
These characteristics make them uniquely valuable in multiple applications: In the biomedical field, they can serve as carriers for drugs, proteins, or growth factors, leveraging pH-responsiveness and tunable degradation to achieve controlled release, while also participating in bone repair and remineralization. In oral care, they promote the remineralization of early enamel carious lesions and represent a key candidate for alternative fluoride-free solutions. Furthermore, through specific modification (e.g., zinc-ion modification), they can be endowed with the ability to refract different wavelengths of UV light, positioning them as a promising raw material for sunscreen development. Additionally, their high surface activity is utilized for the adsorption and removal of heavy metal ions and fluoride.
We offer customized amorphous CaHA and TCP particles, as well as zinc-modified CaHA particles.
Reuse
This product cannot be reused.
Storage
Unopened BG-CHT can be stored at room temperature. Once infiltrated, it needs to be stored at 0.1m NaOH at room temperature. If you use less than 100mM NaOH, add 10mM phosphate. Used CHT cannot be reused.
Sterilization
Both irradiation and wet-heat sterilization can be used.
quality standards
| test items | Standard | method |
appearance | white powder | visual |
positive | General principles of Chinese Pharmacopoeia 2020 Edition (3401) | |
Host protein residue | ≤ 0.005% | General principles of Chinese Pharmacopoeia 2020 Edition (0731) |
Visible foreign body | No particles | General principles of Chinese Pharmacopoeia 2020 Edition (0904) |
PH value | 7.0 - 9.0 | General principles of Chinese Pharmacopoeia 2020 Edition (0631) |
Enzyme activity | ≥ 250kU/mL | In the reaction system of 37 ℃, pH8 and 2.625mL, Δ A was made in 30 minutes.260The amount of enzyme used to completely digest 37 μ g salmon sperm DNA into oligonucleotides was defined as 1 unit of enzyme activity (U). |
purity | ≥ 99% | Chinese Pharmacopoeia 2020 Edition General principles (0541), SEC-HPLC method |
Protease activity | Inactive | 1 kU/ml enzyme, incubated with substrate 37 ℃ for 60 min |
Endotoxin | ≤ 0.01 EU/kU | General principles of Chinese Pharmacopoeia 2020 Edition (1143) |
microbial | Not allowed to check out | General principles of Chinese Pharmacopoeia 2020 Edition (1101) |
Pathogen | Negative | General principles of Chinese Pharmacopoeia 2020 Edition (3306) |
Mycoplasma | Negative | Zhiyuan physical examination test kit, PCR method |
Heavy metal residues | ≤ 10 ppm | General principles of Chinese Pharmacopoeia 2020 Edition (0821) |
Appearance: White powder |
-absorption peak 89325px-1And 15800px-1And PO43-The absorption peak of 27250px-1、 26175px-1、 23975px-1、 15025px-1And 14275px-1There are no absorption peaks of carbonate, carbon, amino or other impurities. |
Endotoxin: < 0.05EU/g |
| PH:6.0-8.0 |
| Trace elements: According to the test results of enterprise standards |
Matters needing attention
Model selection
For the definition of particle size and D10, D50, D90, pleaseClick here.Learn more
For the causes and treatment of adverse events such as granuloma and nodules caused by hydroxyapatite, pleaseClick here.Understand
For a detailed introduction of MP microspheres, pleaseClick here.Understand
For more information, please follow our official account and we will continue to publish articles on hydroxyapatite injection microspheres.